Immunophotonics, SAKK Move Forward with Research Collaboration
Cancer care is entering a new age, transitioning from treatments that attack both cancerous and healthy cells at the same time, to more targeted, specialized therapies that address the root cause of cancer itself without damaging surrounding tissues. Biotech company... Read moreAmerican Entrepreneur – Immunophotonics
iSelect sat down with Immunophotonics CEO Lu Alleruzzo to talk about immunotherapy and innovations in the treatment of cancer
Read more